Artikler
BRIGHT publication
The Bright study demonstrated similar efficacy and safety of Toujeo® (Glargine 300) compared to degludec (insulin degludec) in type 2 diabetes patients who had not previously received basal insulin1.
FLUNITY-HD : the largest individually randomised influenza vaccine effectiveness study of its kind.
FLUNITY-HD is the largest individually randomised influenza vaccine effectiveness study, with nearly half a million older adults across multiple seasons.1
What is Toujeo?
Toujeo is a 2nd generation, long-acting insulin analog containing insulin glargine 300 units/mL. Toujeo® lowers blood glucose levels evenly over a long period of time. It therefore only needs to be administered once a day.
DELIVER-G: Real-world analysis in insulin-naïve adults with T2DM on GLP-1 RA ± OAD(s), intensifying their therapy by starting basal insulin and discontinuing GLP-1 RA, or adding basal insulin to ongoing GLP-1 RA, or initiating a FRC product and discontinuing current GLP-1 RA†1
DELIVER-G: Real-world analysis in insulin-naïve adults with T2DM on GLP-1 RA ± OAD(s), intensifying their therapy by starting basal insulin and discontinuing GLP-1 RA, or adding basal insulin to ongoing GLP-1 RA, or initiating a FRC product and discontinuing current GLP-1 RA†1
EVEREST study: First ever direct Head-to-Head Comparison of Dupilumab vs Omalizumab in Patients with Severe CRSwNP and Coexisting Asthma
First ever direct Head-to-Head Comparison of Dupilumab vs Omalizumab in Patients with Severe CRSwNP and Coexisting Asthma.
How to Use Toujeo®
Toujeo is a 2nd generation, long-acting insulin analog containing insulin glargine 300 units/mL. Toujeo® is available in two prefilled pens. See how Toujeo® is administrated In six simple steps and watch instructional video.
Utdannelse
Oppdaterte behandlingskriterier for Dupixent ved CRSwNP
Overlege Jörg Törpel gir en oppdatering av nye behandlingskriterier for behandling med Dupixent hos personer med alvorlig kronisk rhinosinusitt med nasal polypose (CRSwNP).
FLUNITY-HD: Results of the pooled analysis of the two individually randomized real-world studies, DANFLU 2 and GALFLU
Monday September 15th, 2025 16:00-17:15 CET
A heart for Fabry - Podcast
A podcast series designed by cardiologists, for cardiologists and other healthcare professionals.
Polyp Gossip - latest episode
Polyp Gossip is a video podcast dedicated to exploring Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Hosted by two globally recognized rhinologists. The show delves into trending topics, latest advancements, and patient experiences. Each episode features esteemed guests, including experts and patients, offering valuable insights into the evolving world of CRSwNP.
Polyp Gossip Episode 7: Unified Airways: Bridging Type 2 and Comorbidities in CRSwNP
What links CRSwNP, asthma, and other comorbidities? In this episode, our experts unpack the unified airways concept and why it’s key to understanding Type 2 inflammation and optimizing patient care. Our experts discuss integrated care approaches and what they mean for clinical practice.
Podcasts
Polyp Gossip
Polyp Gossip is a video podcast dedicated to exploring Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Hosted by two globally recognized rhinologists. The show delves into trending topics, latest advancements, and patient experiences.
The Hematology Podcast
Welcome to The Hematology Podcast, your source for the latest insights into hematology and rare blood disorders. This podcast covers cutting-edge research, clinical advancements, and real-world cases tailored for healthcare professionals.
A heart for Fabry - Podcast
A podcast series designed by cardiologists, for cardiologists and other healthcare professionals.
DermTalks
Are you interested in learning more about managing atopic dermatitis in specific patient groups? Look no further and listen to the DermTalks Podcast - Atopic Dermatitis in Special Populations!
Hot topics in atopic dermatitis
This podcast episode highlights an engaging discussion on managing atopic dermatitis, featuring Dr. Andrew Pink, a consultant dermatologist from UK. Emmanuel Tony and Ashlyn Kerry guide the conversation. Dr. Pink discusses the challenges and strategies in treating eczema, emphasizing personalized treatment plans and the importance of patient communication.
RespTalks
Resptalks is a series of scientific webinars & podcasts on current topics related to respiratory diseases such as asthma, chronic rhinosinusitis with nasal polyps, to type 2 inflammation and much more. They are intended for pulmonologists, ENTs, allergologists, pediatricians, scientists from the Nordics countries and the BeNeLux.
Time in range
Denne episoden handler om Time in Range (TIR), som er et ganske nytt behandlingsprinsipp innenfor diabetes og som på norsk kalles ‘tid i målområdet’. Endokrinolog og overlege ved Stavanger Universitetssykehus Sondre Vatne Meling samtaler med podcastvert, lege og adferdsforsker Herman Escher Egenberg.
Treatable Traits & Asthma
A podcast about treatable traits in asthma with Professor Backer, Pavord and Gibson. This podcast is for healthcare professionals that are interested in being updated within asthma or interested in learning more about how to treat asthma patients in the most optimal way according to available science and clinical experiences.